Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Namaka

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Therapeutics|September 1, 2004
A treatment algorithm for neuropathic painMike Namaka, Colin R Gramlich, Dana Ruhlen, et al.
Biomed Research International|November 1, 2013
Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic painWenjun Zhu, Crystal Acosta, Brian MacNeil, et al.
Expert Opinion on Pharmacotherapy|December 17, 2009
Examining the roles of cannabinoids in pain and other therapeutic indications: a reviewDana Turcotte, Josée-Anne Le Dorze, Farid Esfahani, et al.
Journal of Cellular Physiology|February 1, 2006
Bone morphogenetic protein 4 mediates bile duct ligation induced liver fibrosis through activation of Smad1 and ERK1/2 in rat hepatic stellate cellsJianghong Fan, Hong Shen, Yu Sun, et al.
CNS Neuroscience & Therapeutics|December 6, 2017
Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stressesPeng Zhou, Teng Guan, Zhao Jiang, et al.
Pain Medicine (Malden, Mass.)|October 8, 2014
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trialDana Turcotte, Malcolm Doupe, Mahmoud Torabi, et al.
Experimental Neurology|May 5, 2012
CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signalingParvez Vora, Prakash Pillai, Joumana Mustapha, et al.
Current Medical Research and Opinion|February 10, 2006
The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosisMike Namaka, Merinda Pollitt-Smith, Aneri Gupta, et al.
Journal of Cellular and Molecular Medicine|November 5, 2011
The role of dorsal root ganglia activation and brain-derived neurotrophic factor in multiple sclerosisWenjun Zhu, Emma E Frost, Farhana Begum, et al.
Neurological Research|July 18, 2008
Examining the evidence: complementary adjunctive therapies for multiple sclerosisMike Namaka, Arla Crook, Andrea Doupe, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|September 1, 2004
A treatment algorithm for neuropathic painMike Namaka, Colin R Gramlich, Dana Ruhlen, et al.
Biomed Research International|November 1, 2013
Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic painWenjun Zhu, Crystal Acosta, Brian MacNeil, et al.
Expert Opinion on Pharmacotherapy|December 17, 2009
Examining the roles of cannabinoids in pain and other therapeutic indications: a reviewDana Turcotte, Josée-Anne Le Dorze, Farid Esfahani, et al.
Journal of Cellular Physiology|February 1, 2006
Bone morphogenetic protein 4 mediates bile duct ligation induced liver fibrosis through activation of Smad1 and ERK1/2 in rat hepatic stellate cellsJianghong Fan, Hong Shen, Yu Sun, et al.
CNS Neuroscience & Therapeutics|December 6, 2017
Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stressesPeng Zhou, Teng Guan, Zhao Jiang, et al.
Pain Medicine (Malden, Mass.)|October 8, 2014
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trialDana Turcotte, Malcolm Doupe, Mahmoud Torabi, et al.
Experimental Neurology|May 5, 2012
CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signalingParvez Vora, Prakash Pillai, Joumana Mustapha, et al.
Current Medical Research and Opinion|February 10, 2006
The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosisMike Namaka, Merinda Pollitt-Smith, Aneri Gupta, et al.
Journal of Cellular and Molecular Medicine|November 5, 2011
The role of dorsal root ganglia activation and brain-derived neurotrophic factor in multiple sclerosisWenjun Zhu, Emma E Frost, Farhana Begum, et al.
Neurological Research|July 18, 2008
Examining the evidence: complementary adjunctive therapies for multiple sclerosisMike Namaka, Arla Crook, Andrea Doupe, et al.
Pageof 2